Genmab A (GMAB) Net Income Growth (5y) (2024 - 2025)

Genmab A (GMAB) Net Income Growth (5y) (2024 - 2025) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,831.58 Bn	66,831.30 Bn	-
2	Nanobiotix	1,916.61 Bn	1,916.55 Bn	-
3	Akari Therapeutics	976.78 Bn	976.78 Bn	-
4	BeOne Medicines	471.48 Bn	466.69 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.78 Bn	114.53 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	69.87 Bn	61.12 Bn	3.31 Bn
7	Belite Bio	63.06 Bn	63.06 Bn	-
8	Argenx Se	55.78 Bn	50.60 Bn	1.41 Bn
9	Alnylam Pharmaceuticals	37.54 Bn	34.53 Bn	959.66 Mn
10	Genmab A	1.88 Bn	355.27 Mn	831.00 Mn

Download Data